Trial intelligence / Profile preview

Reducing pain on injection of intravenous etomidate using granisetron and lidocaine

IRCT201411025175N19Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of granisetron, lidocaine and etomidate in postoperative pain, sponsored by Tehran University of Medical Sciences. Primary endpoint: Pain on etomidate injection. Started Nov 2014; status: completed.

02

Drugs

granisetronlidocaineetomidate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT201411025175N19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201411025175N19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call